Zhou Y, Liu P, Zhang C, Liao X, Sun J, Liu Y
Front Microbiol. 2020; 10:2957.
PMID: 31969868
PMC: 6960404.
DOI: 10.3389/fmicb.2019.02957.
Nicolas-Chanoine M, Mayer N, Guyot K, Dumont E, Pages J
Front Microbiol. 2018; 9:1422.
PMID: 30008709
PMC: 6034560.
DOI: 10.3389/fmicb.2018.01422.
Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A
Clin Microbiol Rev. 2018; 31(2).
PMID: 29444952
PMC: 5967687.
DOI: 10.1128/CMR.00079-17.
Begum N, Shamsuzzaman S
Tzu Chi Med J. 2017; 28(3):94-98.
PMID: 28757733
PMC: 5442910.
DOI: 10.1016/j.tcmj.2016.04.005.
Toledo P, Aranha Junior A, Arend L, Ribeiro V, Zavascki A, Tuon F
Antimicrob Agents Chemother. 2015; 59(7):4301-4.
PMID: 25896686
PMC: 4468658.
DOI: 10.1128/AAC.00323-15.
Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens.
Lee C, Doi Y
Infect Chemother. 2014; 46(3):149-64.
PMID: 25298904
PMC: 4189141.
DOI: 10.3947/ic.2014.46.3.149.
Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.
Michail G, Labrou M, Pitiriga V, Manousaka S, Sakellaridis N, Tsakris A
Antimicrob Agents Chemother. 2013; 57(12):6028-33.
PMID: 24060874
PMC: 3837854.
DOI: 10.1128/AAC.00891-13.
Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model.
Corvec S, Furustrand Tafin U, Betrisey B, Borens O, Trampuz A
Antimicrob Agents Chemother. 2013; 57(3):1421-7.
PMID: 23295934
PMC: 3591882.
DOI: 10.1128/AAC.01718-12.
Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.
Tzouvelekis L, Markogiannakis A, Psichogiou M, Tassios P, Daikos G
Clin Microbiol Rev. 2012; 25(4):682-707.
PMID: 23034326
PMC: 3485753.
DOI: 10.1128/CMR.05035-11.
New Delhi Metallo-beta lactamase-1 containing enterobacteriaceae: origin, diagnosis, treatment and public health concern.
Charan J, Mulla S, Ryavanki S, Kantharia N
Pan Afr Med J. 2012; 11:22.
PMID: 22514756
PMC: 3325060.
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Neuner E, Yeh J, Hall G, Sekeres J, Endimiani A, Bonomo R
Diagn Microbiol Infect Dis. 2011; 69(4):357-62.
PMID: 21396529
PMC: 3058153.
DOI: 10.1016/j.diagmicrobio.2010.10.013.
New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: emerging resistance.
Pillai D, McGeer A, Low D
CMAJ. 2011; 183(1):59-64.
PMID: 21220461
PMC: 3017254.
DOI: 10.1503/cmaj.101487.
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
Cai Y, Wang R, Liang B, Bai N, Liu Y
Antimicrob Agents Chemother. 2010; 55(3):1162-72.
PMID: 21173186
PMC: 3067123.
DOI: 10.1128/AAC.01402-10.
Multidrug-resistant Gram-negative infections: what are the treatment options?.
Giamarellou H, Poulakou G
Drugs. 2009; 69(14):1879-901.
PMID: 19747006
DOI: 10.2165/11315690-000000000-00000.
Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome.
Falcone M, Mezzatesta M, Perilli M, Forcella C, Giordano A, Cafiso V
J Clin Microbiol. 2009; 47(11):3514-9.
PMID: 19741074
PMC: 2772607.
DOI: 10.1128/JCM.01193-09.
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
Principe L, DArezzo S, Capone A, Petrosillo N, Visca P
Ann Clin Microbiol Antimicrob. 2009; 8:18.
PMID: 19460166
PMC: 2693502.
DOI: 10.1186/1476-0711-8-18.
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.
Kelesidis T, Karageorgopoulos D, Kelesidis I, Falagas M
J Antimicrob Chemother. 2008; 62(5):895-904.
PMID: 18676620
PMC: 8445635.
DOI: 10.1093/jac/dkn311.
A novel SHV-type beta-lactamase variant (SHV-89) in clinical isolates in China.
Li J, Cheng J, Wang Q, Chen Y, Ye Y, Zhang X
Mol Biol Rep. 2008; 36(5):1141-8.
PMID: 18587684
DOI: 10.1007/s11033-008-9290-8.